Monica is a Senior Director in Alliance Management, part of Corporate Development.  As Alliance Manager, Monica has successfully developed and maintained important Gilead alliances: filgotinib (Galapagos) Atripla (BMS), Tamiflu (Roche), Vitekta and Stribild (JT) and, Viread for China and Japan (GSK).  Additionally, Monica has supported business development in numerous in-licensing efforts and has played a key role in negotiations for significant contract amendments.  

Monica joined Gilead in 2002.  Initially she managed a variety of projects in the antiviral portfolio, both in R&D and in life cycle management (including Truvada and Atripla). Later she became the Therapeutic Area PPM lead for HIV antivirals.  She also took on a key role in the development and execution of Gilead’s Portfolio Review.

Prior to Gilead, Monica was with GSK for 6 years, initially as a Medicinal Chemist and later in the Project Management group.  Prior to that, she was a Medicinal Chemist at the Schering Plough Research Institute. 

Monica has industry experience in multiple therapeutic areas, including Oncology, Inflammation, HIV, Hepatitis, CNS and CV.

Monica received her PhD in Chemistry and Industrial Technologies at the University of Milan.